Free Delivery Over $100
|
|
|||
|
||||
OverviewOn 29 February 1964, a group of European scientists met in Paris to discuss a subject of common interest, namely atherosclerosis research, with particular reference to international communication and collaboration. After a second meeting on 15 May 1964, they founded the European Atherosclerosis Group which was to com- prise individuals engaged in the various disciplines of atherosclero- sis research in Eastern and Western Europe. Since then this group has initiated multidisciplinary discussion and scientific collabora- tion across Europe, in accordance with the objects and aims written in its statutes: 1. To hold colloquia and symposia dealing with research in the field of atherosclerosis and allied sciences 2. To encourage meetings and exchanges between scientists in the group engaged in the investigation of atherosclerosis 3. To encourage collaborative work between national and interna- tional centers engaged in atherosclerosis research 4. To encourage the publication of reviews, etc. , on atherosclerosis research which may be considered of value 5. To promote research fellowships, particularly for younger research workers, for studies within the field of atherosclerosis and allied sciences 6. To accept dues, endowments, grants, funds, and bequests to be used for the above purposes The European Atherosclerosis Group has helped to bring together what was separated during the second world war and the postwar period in Europe and to reestablish ties with the leading American teams. Full Product DetailsAuthor: Gunter Schlierf , Hubert MorlPublisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Imprint: Springer-Verlag Berlin and Heidelberg GmbH & Co. K Weight: 0.920kg ISBN: 9783540173656ISBN 10: 354017365 Pages: 379 Publication Date: 01 April 1987 Audience: College/higher education , Professional and scholarly , Undergraduate , Postgraduate, Research & Scholarly Format: Hardback Publisher's Status: Out of Print Availability: Out of stock  Table of ContentsPathogenesis and Morphology.- Pathogenesis of Atherosclerosis: - Current Status.- The Extracellular Matrix of the Vessel Wall, Its Role and Modification During the Atherosclerotic Process.- Changing Views of the Morphology of Atherosclerosis.- Atherosclerosis as a Recurrent Cycle of Inflammation and Repair.- Non-Arterial Deposition of Lipids and Lipoproteins: Significance in Relation to Atherogenesis.- On the Role of Lipoprotein Antibody Immune Complexes in Atherogenesis.- Role of Different Agents Affecting Endothelial Cells in the Process of Atherosclerosis - In Vitro Examinations.- On the Delayed Experimental Pathologic Involvement of Cerebral Arteries in Hypercholesterolemic Monkeys, Rabbits and Spontaneously Hypertensive Rats.- Enzyme-Acylalcohol-Alcohol Interactions in the Arterial Wall.- The Effect of Balloon De-Endothelialization on Arterial Enzymes and Metabolic Intermediates in Rabbits.- Epidemiology, Risk Factors.- Coronary Heart Disease Epidemiology - Perspectives.- Obesity and Cardiovascular Disease.- Lipoproteins and Apolipoproteins in the Prediction of Coronary Artery Disease.- Prevalence of Hyperlipidaemia in British Compared with North American Men.- Low-Density Lipoprotein: Its Metabolic Determinants and Its Role in Coronary Heart Disease.- Plasma Levels of Lipoproteins and Apolipoproteins in Octo- and Nonagenarians.- Cholesteryl Ester Transfer, Lipoproteins, Hypertriglyceridemia, and Atherosclerosis.- Importance of Hypertriglyceridemia as an Independent Risk Factor: Investigations with Familial Combined Hyperlipidemia and Familial Hypertriglyceridemia.- The Plasma Lipoproteins in Hypertriglyceridemia as Risk Factors for Atherosclerosis.- Myocardial Infarction in Women on Oral Contraceptives: Risk Factors and Mechanism.- Combined Oral Contraceptives: From Risk to Benefit?.- Bile Acids, Lipoproteins, and Atherosclerosis.- Metabolic Abnormalities in Cerebral and Peripheral Arteriosclerosis.- Elastase-Type Enzymes and Their Relation to Blood Lipids and Atherosclerosis.- DNA Polymorphisms for the Genetic Analysis of Atherosclerosis.- Lipoproteins.- Chylomicron Catabolism and Uptake by the Liver.- Lipoprotein Lipase, Synthesis and Regulation.- Structural and Clinical Aspects of the Plasma Phospholipid Subclasses.- Irregular Working Hours and Lipid Levels in Men.- Identification and Computer Modeling of Functional Domains in Plasma Apolipoproteins.- New Perspectives in Human Apolipoprotein B Metabolism.- Fish Eye Disease: Implications for the Understanding of Cardiovascular Disease and Plasma Lipoprotein Metabolism.- Diabetes.- Vascular Growth Factors and Atherogenesis in Diabetes Mellitus.- Cholesterol Biosynthesis in Diabetes Mellitus.- Effects of Diet Fat Composition on Serum Lipids and Lipoproteins in Patients with Insulin-Dependent Diabetes Mellitus.- Platelets and Thrombosis.- ss2-Glycoprotein-I (Apolipoprotein H): Possible Role in Platelet Activation and Coagulation.- Diet, Lipoproteins and Atherosclerosis.- Changes in Diet, Serum Cholesterol, and Mortality from Coronary Heart Disease in Spain.- Modified Fat Diets and Serum Lipoproteins.- Essential Fatty Acids, Marine Oils, Olive Oil and Coronary Heart Disease.- What Are the Alpha-Linolenic Acid Supplies to Be Recommended to the Normal Adult?.- Animal and Vegetable Protein Effects in Experimental Atherosclerosis.- Food Proteins and Atherosclerosis.- Cholesterol-Lowering and High-Density Lipoprotein-Raising Properties of Lecithinated Soy Proteins in Type II Hyperlipidemic Patients.- Prevention and Therapy.- From Theory to Practice: Community-Based Studies on the Prevention of Coronary Heart Disease.- Regression of Atherosclerosis in Man.- Plasma Exchange and Its Development in the Treatment of Familial Hypercholesterolemia.- The HELP System: A Novel Technique for the Extracorporeal Treatment of Familial Hypercholesterolemia.- Plasma Exchange for Severe Forms of Familial Hypercholesterolemia: 10 Years' (23 Patient Years') Experience.ReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||
